Blanchette Rockefeller Neurosciences Institute seeks to provide the general public and members of the media and with quick and easy access to recent information about the Institute.
The information set forth in each press release posted on this page was factually accurate on the date it was issued. These press releases remain on the Institute's website for purposes of historical perspective and the Institute does not update or change the original release to reflect subsequent developments.
Bryostatin, a PKC epsilon Activator, Generates New Synapses Through Accumulation of the Synaptic Anchoring Protein PSD-95 at Neuronal Membranes
June 21, 2016 — June 21, 2016
Bryostatin, currently in a phase 2 clinical trial, causes regeneration of synaptic networks in both Alzheimer's and Fragile X mouse models, neurodegenerative diseases at both ends of the age spectrum.
Major Alzheimer’s Risk Gene Opens New Pathway to Prevention
May 13, 2015 — Major Alzheimer’s Risk Gene Opens New Pathway to Prevention
Linkage of Alzheimer’s gene to early synaptic loss provides evidence for a new focus in Alzheimer’s research and treatment
Morgantown, WV – May 13, 2015 – In a groundbreaking new study,...
Severe Alzheimer's Patient Responds to Bryostatin Treatment
March 30, 2015 — Severe Alzheimer's Patient
Responds to Bryostatin Treatment
Identify PSEN1 Thr147lle Variant in Family
Early Onset Dementia and Expressive Aphasia
Morgantown, WV - March 30, 2015 -
Researchers at the...